These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 19675224)
1. Highly efficient antiviral CD8+ T-cell induction by peptides coupled to the surfaces of liposomes. Takagi A; Matsui M; Ohno S; Duan H; Moriya O; Kobayashi N; Oda H; Mori M; Kobayashi A; Taneichi M; Uchida T; Akatsuka T Clin Vaccine Immunol; 2009 Oct; 16(10):1383-92. PubMed ID: 19675224 [TBL] [Abstract][Full Text] [Related]
2. Coupling to the surface of liposomes alters the immunogenicity of hepatitis C virus-derived peptides and confers sterile immunity. Takagi A; Kobayashi N; Taneichi M; Uchida T; Akatsuka T Biochem Biophys Res Commun; 2013 Jan; 430(1):183-9. PubMed ID: 23159619 [TBL] [Abstract][Full Text] [Related]
3. CpG-DNA activates in vivo T cell epitope presenting dendritic cells to trigger protective antiviral cytotoxic T cell responses. Vabulas RM; Pircher H; Lipford GB; Häcker H; Wagner H J Immunol; 2000 Mar; 164(5):2372-8. PubMed ID: 10679072 [TBL] [Abstract][Full Text] [Related]
4. Archaeosomes induce long-term CD8+ cytotoxic T cell response to entrapped soluble protein by the exogenous cytosolic pathway, in the absence of CD4+ T cell help. Krishnan L; Sad S; Patel GB; Sprott GD J Immunol; 2000 Nov; 165(9):5177-85. PubMed ID: 11046050 [TBL] [Abstract][Full Text] [Related]
5. In vivo induction of a high-avidity, high-frequency cytotoxic T-lymphocyte response is associated with antiviral protective immunity. Sedlik C; Dadaglio G; Saron MF; Deriaud E; Rojas M; Casal SI; Leclerc C J Virol; 2000 Jul; 74(13):5769-75. PubMed ID: 10846055 [TBL] [Abstract][Full Text] [Related]
6. Antigen chemically coupled to the surface of liposomes are cross-presented to CD8+ T cells and induce potent antitumor immunity. Taneichi M; Ishida H; Kajino K; Ogasawara K; Tanaka Y; Kasai M; Mori M; Nishida M; Yamamura H; Mizuguchi J; Uchida T J Immunol; 2006 Aug; 177(4):2324-30. PubMed ID: 16887993 [TBL] [Abstract][Full Text] [Related]
7. Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors. Ossendorp F; Mengedé E; Camps M; Filius R; Melief CJ J Exp Med; 1998 Mar; 187(5):693-702. PubMed ID: 9480979 [TBL] [Abstract][Full Text] [Related]
8. Liposome-coupled peptides induce long-lived memory CD8 T cells without CD4 T cells. Taneichi M; Tanaka Y; Kakiuchi T; Uchida T PLoS One; 2010 Nov; 5(11):e15091. PubMed ID: 21264321 [TBL] [Abstract][Full Text] [Related]
9. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection. Matloubian M; Concepcion RJ; Ahmed R J Virol; 1994 Dec; 68(12):8056-63. PubMed ID: 7966595 [TBL] [Abstract][Full Text] [Related]
10. 4-1BB costimulation is required for protective anti-viral immunity after peptide vaccination. Tan JT; Whitmire JK; Murali-Krishna K; Ahmed R; Altman JD; Mittler RS; Sette A; Pearson TC; Larsen CP J Immunol; 2000 Mar; 164(5):2320-5. PubMed ID: 10679066 [TBL] [Abstract][Full Text] [Related]
11. CD4-deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent virus challenge. von Herrath MG; Yokoyama M; Dockter J; Oldstone MB; Whitton JL J Virol; 1996 Feb; 70(2):1072-9. PubMed ID: 8551565 [TBL] [Abstract][Full Text] [Related]
12. A protective cytotoxic T cell response to a subdominant epitope is influenced by the stability of the MHC class I/peptide complex and the overall spectrum of viral peptides generated within infected cells. Gallimore A; Hombach J; Dumrese T; Rammensee HG; Zinkernagel RM; Hengartner H Eur J Immunol; 1998 Oct; 28(10):3301-11. PubMed ID: 9808199 [TBL] [Abstract][Full Text] [Related]
13. Intranasal administration of a synthetic peptide vaccine encapsulated in liposome together with an anti-CD40 antibody induces protective immunity against influenza A virus in mice. Ninomiya A; Ogasawara K; Kajino K; Takada A; Kida H Vaccine; 2002 Aug; 20(25-26):3123-9. PubMed ID: 12163263 [TBL] [Abstract][Full Text] [Related]
14. Vaccination with immunodominant peptides encapsulated in Quil A-containing liposomes induces peptide-specific primary CD8+ cytotoxic T cells. Lipford GB; Wagner H; Heeg K Vaccine; 1994 Jan; 12(1):73-80. PubMed ID: 8303944 [TBL] [Abstract][Full Text] [Related]
15. Priming for virus-specific CD8+ but not CD4+ cytotoxic T lymphocytes with synthetic lipopeptide is influenced by acylation units and liposome encapsulation. Babu JS; Nair S; Kanda P; Rouse BT Vaccine; 1995 Dec; 13(17):1669-76. PubMed ID: 8719518 [TBL] [Abstract][Full Text] [Related]
16. Cross-priming of T cell responses by synthetic microspheres carrying a CD8+ T cell epitope requires an adjuvant signal. Boisgérault F; Rueda P; Sun CM; Hervas-Stubbs S; Rojas M; Leclerc C J Immunol; 2005 Mar; 174(6):3432-9. PubMed ID: 15749877 [TBL] [Abstract][Full Text] [Related]
17. Adenovirus-based vaccine against Listeria monocytogenes: extending the concept of invariant chain linkage. Jensen S; Steffensen MA; Jensen BA; Schlüter D; Christensen JP; Thomsen AR J Immunol; 2013 Oct; 191(8):4152-64. PubMed ID: 24043891 [TBL] [Abstract][Full Text] [Related]